Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology
Küçük Resim Yok
Tarih
2022
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Springernature
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Background: Recent advances in nanotechnology have offered new hope for cancer detection, prevention, and treatment. Nanomedicine, a term for the application of nanotechnology in medical and health fields, uses nanoparticles for several applications such as imaging, diagnostic, targeted cancer therapy, drug and gene delivery, tissue engineering, and theranostics. Results: Here, we overview the current state-of-the-art of radiolabeled nanoparticles for molecular imaging and radionuclide therapy. Nanostructured radiopharmaceuticals of technetium-99m, copper-64, lutetium-177, and radium-223 are discussed within the scope of this review article. Conclusion: Nanoradiopharmaceuticals may lead to better development of theranostics inspired by ingenious delivery and imaging systems. Cancer nano-theranostics have the potential to lead the way to more specific and individualized cancer treatment.
Açıklama
Anahtar Kelimeler
Radiolabeled nanoparticles, Technetium-99m, Copper-64, Lutetium-177, Radium-223, Molecular imaging, Radionuclide therapy, Theranostics, Toxicity, Radiopharmacy, Mesoporous Silica Nanoparticles, Iron-Oxide Nanoparticles, Drug Delivery-System, Lymph-Node Biopsy, In-Vitro, Radionuclide Therapy, Lipid Nanoparticles, Cellular Uptake, Cancer-Therapy, Surface-Charge
Kaynak
Ejnmmi Radiopharmacy and Chemistry
WoS Q Değeri
N/A
Scopus Q Değeri
Q1
Cilt
7
Sayı
1
